Kai Ding to Angiogenesis Inhibitors
This is a "connection" page, showing publications Kai Ding has written about Angiogenesis Inhibitors.
Connection Strength
0.109
-
Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. Gynecol Oncol. 2014 Apr; 133(1):11-5.
Score: 0.109